Announcements

Twenty One Capital, Inc. filed its quarterly report on Form 10-Q with the SEC for the quarterly period ended June 30, 2026, disclosing condensed consolidated financial statements and related information as of that date.

Twenty One Capital, Inc. filed a Form 8-K with the SEC on August 11, 2026, disclosing that Chief Executive Officer Raphael Zagury issued a letter to shareholders on the same date, furnished under Regulation FD.

Upstream Bio, Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on August 11, 2026, covering the fiscal quarter ended June 30, 2026.

Kardigan, Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on August 11, 2026, covering the fiscal quarter ended June 30, 2026.

Tango Therapeutics, Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on August 11, 2026, covering the fiscal quarter ended June 30, 2026.

Aura Biosciences, Inc. filed a Form 8-K on August 11, 2026, disclosing an organizational realignment, a planned workforce reduction of approximately 20%, the appointment of Susan Abu-Absi, Ph.D. as Chief Operating Officer, and the announcement of financial results for the quarter ended June 30, …

908 Devices Inc. filed its Form 10-Q for the quarterly period ended June 30, 2026 with the U.S. Securities and Exchange Commission, disclosing condensed consolidated balance sheet data and related financial statements.